Navigation Links
Sun Yat-sen University and Johns Hopkins sign collaboration agreement
Date:3/4/2013

The training of next-generation clinical investigators in China is at the core of a new collaboration between Sun Yat-sen University (SYSU) and its affiliated hospitals in Guangzhou, China, and The Johns Hopkins University and Johns Hopkins Medicine International in Baltimore, USA.

The agreement between the academic medical centers was signed today in Guangzhou. It will provide a long-term platform for exchanges among clinical and translational investigators, research professionals and administrators in both countries, and will lay the foundation for building world-class research infrastructure in China, according to representatives of both institutions.

"China's health care sector and biomedical research field are growing rapidly," says Daniel Ford, M.D., M.P.H., professor and vice dean of clinical investigation at the Johns Hopkins University School of Medicine. "We are honored to have this opportunity to collaborate with SYSU and its affiliated hospitals to improve research processes, infrastructure and systems. We see this endeavor as a natural extension of Johns Hopkins Medicine's global mission and vision."

"We look forward to working with our colleagues at Johns Hopkins in the areas of clinical and translational research," says Ningsheng Xu, Ph.D., president of SYSU. "We firmly believe that this endeavor will become a milestone in the globalization of our university. The sharing of knowledge between our two institutions will help advance medical science and health care delivery in China, the United States and beyond."

In the first phase of the collaboration, Johns Hopkins experts will travel to SYSU to teach courses and lead workshops designed to strengthen development of investigators and research professionals. These experts also will design a competitive fellowship program at Johns Hopkins for promising SYSU investigators and junior faculty members, and provide strategic and technical advice on a wide range of issues that include research infrastructure, operations, safety and governance.

The agreement will also provide seed grants for collaborative clinical and translational pilot projects that have the potential to develop into larger studies funded by industry or government sources in China and the United States.

"This collaboration demonstrates our commitment to becoming a regional leader in clinical and translational research," says Mengfeng Li, Ph.D., vice president of SYSU and dean of SYSU's Zhongshan School of Medicine. "It is an opportunity for us to leverage Johns Hopkins' expertise in the discovery and application of the latest research advances. We are confident that the sooner we can enhance our training programs and research infrastructure, the sooner we can foster the kind of international collaborative research that will make a difference in people's lives in China and throughout the world."


'/>"/>

Contact: Natalia Abel
nboloti1@jhmi.edu
410-464-6645
Johns Hopkins Medicine
Source:Eurekalert

Related medicine news :

1. Members of University Services Sleep Diagnostic & Treatment Centers Wake Up Industries and Communities to the Importance of Sleep for Sleep Awareness Week
2. Book by University of Oregon psychologists opens eyes on betrayal
3. Case Western Reserve University joins BrainGate clinical trial
4. Baylor University researchers study barriers, resources to physical activity in Texas towns
5. Animal Cell Therapies, Inc. and University of Florida Receive $330k Grant from The Sabes Foundation for Stem Cell Study
6. Rice University analysis links ozone levels, cardiac arrest
7. NIKE Softball Camps Announces New Northeast Location at Bryant University
8. Quality Communication Solutions to Participate in Career Fair at Drake University in Des Moines, Iowa on February 14, 2013
9. Students in Educational First Steps Assisted Centers Show Persistent Benefits Far Beyond Early Childhood According to University of Texas at Dallas Study
10. University of Minnesota researchers discover enzyme behind breast cancer mutations
11. University of California Irvine, Medical Center Selects Jvion as their ICD-10 Risk Assessment and Crosswalk Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in property taxes a year. In some states—like New York, New Jersey, Massachusetts, ... contrast, many overseas retirement havens have extremely low property-tax rates, which contributes to ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: